Overview Fundamentals API Earnings EOD API Sample Code Pricing

Oasmia Pharmaceutical AB (OASMY PINK) stock market data APIs

$0.0499 0(0%) as of July 17, 2024
Price chart is built with Anychart

Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.

Oasmia Pharmaceutical AB Financial Data Overview

0.0499
0.0499
-
0.0499
0.0499
0.0002-0.05
14 027 K
179 M
6 612 K
-0.0045
0.631
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'OASMY',
Type: 'Common Stock',
Name: 'Oasmia Pharmaceutical AB',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG009SYD7H7',
ISIN: NULL,
CUSIP: NULL,
CIK: '1607245',
EmployerIdNumber: NULL,
FiscalYearEnd: 'April',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
HomeCategory: NULL,
IsDelisted: false,
}

Oasmia Pharmaceutical AB Fundamental Data is available in our Financial Data APIs

  • Net Revenue 6 612 K
  • EBITDA -68 304 000
  • Earnings Per Share -0.06
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Oasmia Pharmaceutical AB Earnings via APIs

  • Latest Release 2024-05-23
  • EPS/Forecast NaN

Get Oasmia Pharmaceutical AB End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com